Access cutting-edge binge eating disorder treatment through this clinical trial at a research site in Encino. Study-provided care at no cost to qualified participants.
Access binge eating disorder specialists in Encino at no cost
This study follows strict safety protocols and ethical guidelines
All study-related binge eating disorder treatment provided free
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
Sponsor: Axsome Therapeutics, Inc.
Check if you qualify for this binge eating disorder clinical trial in Encino, CA
If you're searching for binge eating disorder treatment options in Encino, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced binge eating disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.